TY - JOUR
T1 - Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
AU - Danen-van Oorschot, Astrid A.
AU - Kuipers, Jenny E.
AU - Arentsen-Peters, Susan
AU - Schotte, Diana
AU - de Haas, Valerie
AU - Trka, Jan
AU - Baruchel, André
AU - Reinhardt, Dirk
AU - Pieters, Rob
AU - Michel Zwaan, C.
AU - van den Heuvel-Eibrink, Marry M.
PY - 2012/5
Y1 - 2012/5
N2 - Background: miRNAs regulate gene expression, and thus play an important role in critical cellular processes. Aberrant miRNA expression patterns have been found in various types of cancer. So far, information about the expression of miRNAs in pediatric acute myeloid leukemia is limited. Procedure: We studied expression of miR-29a, -155, -196a, and -196b by stem-loop based RT-qPCR in 82 pediatric acute myeloid leukemia patients selected to represent relevant cytogenetic and molecular subgroups. Results: High miR-196a and -b expression was observed in patients carrying MLL gene rearrangements (P<0.001), NPM1 mutations (P<0.001), or FLT3-ITD in a cytogenetically normal background (P≤0.02), compared to all other patients. In contrast, CEBPA mutated cases had a low expression of miR-196a and -b (P≤0.001). Expression of miR-196a and -b was correlated with expression of neighboring HOXA and HOXB genes (Spearman's r=0.46-0.82, P<0.01). Expression of miR-155 was not related to cytogenetic features but high expression of miR-155 was observed in FLT3-ITD (P=0.001) and NPM1-mutated cases (P=0.04). Lower miR-29a expression was mainly observed in MLL-rearranged pediatric acute myeloid leukemia, specifically in cases carrying t(10;11) (P<0.001). Conclusions: We show aberrant expression of specific miRNAs in clinically relevant cytogenetic and molecular subgroups of pediatric acute myeloid leukemia, suggesting a role for these miRNAs in the underlying biology in these specific subgroups.
AB - Background: miRNAs regulate gene expression, and thus play an important role in critical cellular processes. Aberrant miRNA expression patterns have been found in various types of cancer. So far, information about the expression of miRNAs in pediatric acute myeloid leukemia is limited. Procedure: We studied expression of miR-29a, -155, -196a, and -196b by stem-loop based RT-qPCR in 82 pediatric acute myeloid leukemia patients selected to represent relevant cytogenetic and molecular subgroups. Results: High miR-196a and -b expression was observed in patients carrying MLL gene rearrangements (P<0.001), NPM1 mutations (P<0.001), or FLT3-ITD in a cytogenetically normal background (P≤0.02), compared to all other patients. In contrast, CEBPA mutated cases had a low expression of miR-196a and -b (P≤0.001). Expression of miR-196a and -b was correlated with expression of neighboring HOXA and HOXB genes (Spearman's r=0.46-0.82, P<0.01). Expression of miR-155 was not related to cytogenetic features but high expression of miR-155 was observed in FLT3-ITD (P=0.001) and NPM1-mutated cases (P=0.04). Lower miR-29a expression was mainly observed in MLL-rearranged pediatric acute myeloid leukemia, specifically in cases carrying t(10;11) (P<0.001). Conclusions: We show aberrant expression of specific miRNAs in clinically relevant cytogenetic and molecular subgroups of pediatric acute myeloid leukemia, suggesting a role for these miRNAs in the underlying biology in these specific subgroups.
KW - MiR-155
KW - MiR-196
KW - MiR-29a
KW - MiRNAs
KW - Pediatric AML
UR - http://www.scopus.com/inward/record.url?scp=84857870463&partnerID=8YFLogxK
U2 - 10.1002/pbc.23279
DO - 10.1002/pbc.23279
M3 - Article
C2 - 21818844
AN - SCOPUS:84857870463
SN - 1545-5009
VL - 58
SP - 715
EP - 721
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
IS - 5
ER -